A GENETIC screening test for prostate cancer could be here within two years,
say researchers who have discovered gene variations linked to the disease.
Prostate cancer is the commonest form of cancer in men, and kills 32,000 each
year in the US alone.
Sean Tavtigian of Myriad Genetics in Salt Lake City and his colleagues have
found variations in a gene called HPC2 in a region of chromosome 17
that affects the risk of getting prostate cancer. In 1996, University of Utah
scientists linked this region to a familial prostate cancer.
“We’re thrilled. We’ve been looking for ten years,” says Lisa Albright at the…
